Merck owns one of the best drugs in the world, Keytruda. The company has a solid growth outlook going forward. An inexpensive valuation and a solid dividend yield round out the positive picture.

Retail investors often monitor the trading activity of members of Congress. Investors may want to pay particular attention to recent trades from one member, with stocks connected to Elon Musk and ...

Johnson & Johnson has increased its dividend for 64 consecutive years. Merck has raised its dividend for 26 consecutive years. Both drug companies spend heavily on R&D. 10 stocks we like better than ...